EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Attention-based approach to predict drug–target interactions across seven target superfamilies

Aron Schulman, Juho Rousu iD, Tero Aittokallio iD, Ziaurrehman Tanoli iD

Bioinformatics · 02.08.2024 · 40 (8)

DOI: 10.1093/bioinformatics/btae496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 08.08.2024. Verfasst von Aron Schulman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland. Hauptthemen laut MEDLINE: Drug Repositioning. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Drug–target interactions (DTIs) hold a pivotal role in drug repurposing and elucidation of drug mechanisms of action. While single-targeted drugs have demonstrated clinical success, they often exhibit limited efficacy against complex diseases, such as cancers, whose development and treatment is dependent on several biological processes. Therefore, a comprehensive understanding of primary, secondary and even inactive targets becomes essential in the quest for effective and safe treatments for cancer and other indications. The human proteome offers over a thousand druggable targets, yet most FDA-approved drugs bind to only a small fraction of these targets. Results This study introduces an attention-based method (called as MMAtt-DTA) to predict drug–target bioactivities across human proteins within seven superfamilies. We meticulously examined nine different descriptor sets to identify optimal signature descriptors for predicting novel DTIs. Our testing results demonstrated Spearman correlations exceeding 0.72 (P < 0.001) for six out of seven superfamilies. The proposed method outperformed fourteen state-of-the-art machine learning, deep learning and graph-based methods and maintained relatively high performance for most target superfamilies when tested with independent bioactivity data sources. We computationally validated 185 676 drug–target pairs from ChEMBL-V33 that were not available during model training, achieving a reasonable performance with Spearman correlation >0.57 (P < 0.001) for most superfamilies. This underscores the robustness of the proposed method for predicting novel DTIs. Finally, we applied our method to predict missing bioactivities among 3492 approved molecules in ChEMBL-V33, offering a valuable tool for advancing drug mechanism discovery and repurposing existing drugs for new indications. Availability and implementation https://github.com/AronSchulman/MMAtt-DTA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningHumansProteinsMachine LearningComputational BiologyDrug Discovery

Substanzen

Proteins

Autor:innen und Institutionen

  • Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, 00014, Finland.
  • Department of Computer Science, Aalto University, Espoo, 02150, Finland.
  • iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, 00014, Finland.
  • Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, 0379, Norway.
  • Oslo Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo, Oslo, 0372, Norway.
  • Drug Discovery and Chemical Biology (DDCB) Consortium, Biocenter, Helsinki, 00014, Finland.

ORCID-Profile: Juho Rousu, Tero Aittokallio, Ziaurrehman Tanoli

Förderung

  • Research Council of Finland

Zitieren

APA

Schulman, A., Rousu, J., Aittokallio, T., & Tanoli, Z. (2024). Attention-based approach to predict drug–target interactions across seven target superfamilies. Bioinformatics, 40(8). https://doi.org/10.1093/bioinformatics/btae496

Vancouver

Schulman A, Rousu J, Aittokallio T, Tanoli Z. Attention-based approach to predict drug–target interactions across seven target superfamilies. Bioinformatics. 2024;40(8). doi:10.1093/bioinformatics/btae496

BibTeX
@article{Schulman2024,
  author = {Schulman, Aron and Rousu, Juho and Aittokallio, Tero and Tanoli, Ziaurrehman},
  title = {Attention-based approach to predict drug–target interactions across seven target superfamilies},
  journal = {Bioinformatics},
  year = {2024},
  volume = {40},
  number = {8},
  doi = {10.1093/bioinformatics/btae496}
}
Kostenlos starten →